| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.0008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |